HIGHLIGHTS
SUMMARY
Both tumor cells and myeloid cells express cGAS/STING, but accumulating evidence suggests that cGAMP is primarily produced by tumor cells and released as an immunotransmitter to activate STING in myeloid cells and stimulate antitumor immunity by triggering Type I IFN production(6-8). TAMs can promote immunosuppression and inhibit anti-tumor T_cell responses, thereby limiting the efficacy of checkpoint inhibitors(15-18). Mice with PP2Ac deficiency in macrophages exhibited reduced tumor growth, increased tumor-infiltrating 3 CD8+ T_cell and reduction of immunosuppressive macrophages. PP2Ac negatively regulates STING-Type I IFN signaling pathway To . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.